Paper41439366
GALNT7 promotes hepatocellular carcinoma progression by activating the PI3K/AKT signaling pathway via O-glycosylation of MUC13.
Liang L and 12 others. Acta Biochim Biophys Sin (Shanghai), 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. GALNT7 promotes hepatocellular carcinoma progression by activating the PI3K/AKT signaling pathway via O-glycosylation of MUC13. Papers, record 41439366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41439366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- GALNT7 promotes hepatocellular carcinoma progression by activating the PI3K/AKT signaling pathway via O-glycosylation of MUC13.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Hepatocellular | Major topic |
| Liver Neoplasms | Major topic |
| N-Acetylgalactosaminyltransferases | Major topic |
| Proto-Oncogene Proteins c-akt | Major topic |
| Signal Transduction | Major topic |
| Phosphatidylinositol 3-Kinases | Major topic |
| Mucins | Major topic |
| Humans | |
| Glycosylation | |
| Polypeptide N-acetylgalactosaminyltransferase | |
| Animals | |
| Cell Proliferation | |
| Disease Progression | |
| Cell Line, Tumor | |
| Mice | |
| Male | |
| Cell Movement | |
| Mice, Nude | |
| Gene Expression Regulation, Neoplastic | |
| Mice, Inbred BALB C |
Source PubMed
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37633945 | SPDEF enhances cancer stem cell-like properties and tumorigenesis through directly promoting GALNT7 transcription in luminal breast cancer. | Cell Death Dis | 2023 | https://conductscience.org/library/papers/37633945 | PubMed |
| 2 | 29307467 | Hepatocellular carcinoma. | Lancet | 2018 | https://conductscience.org/library/papers/29307467 | PubMed |
| 3 | 22183981 | Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family. | Glycobiology | 2012 | https://conductscience.org/library/papers/22183981 | PubMed |
| 4 | 32308562 | miR-125a-5p post-transcriptionally suppresses GALNT7 to inhibit proliferation and invasion in cervical cancer cells via the EGFR/PI3K/AKT pathway. | Cancer Cell Int | 2020 | https://conductscience.org/library/papers/32308562 | PubMed |
| 5 | 33813658 | Mucins reprogram stemness, metabolism and promote chemoresistance during cancer progression. | Cancer Metastasis Rev | 2021 | https://conductscience.org/library/papers/33813658 | PubMed |
| 6 | 32060138 | GCNT1-Mediated O-Glycosylation of the Sialomucin CD43 Is a Sensitive Indicator of Notch Signaling in Activated T Cells. | J Immunol | 2020 | https://conductscience.org/library/papers/32060138 | PubMed |
| 7 | 36725887 | Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth. | Oncogene | 2023 | https://conductscience.org/library/papers/36725887 | PubMed |
| 8 | 19176398 | Expression and functions of transmembrane mucin MUC13 in ovarian cancer. | Cancer Res | 2009 | https://conductscience.org/library/papers/19176398 | PubMed |
| 9 | 27321183 | MUC13 interaction with receptor tyrosine kinase HER2 drives pancreatic ductal adenocarcinoma progression. | Oncogene | 2017 | https://conductscience.org/library/papers/27321183 | PubMed |
| 10 | 24097071 | Functions and regulation of MUC13 mucin in colon cancer cells. | J Gastroenterol | 2014 | https://conductscience.org/library/papers/24097071 | PubMed |
| 11 | 36429094 | A Sweet Warning: Mucin-Type O-Glycans in Cancer. | Cells | 2022 | https://conductscience.org/library/papers/36429094 | PubMed |
| 12 | 29251719 | Expression system for structural and functional studies of human glycosylation enzymes. | Nat Chem Biol | 2018 | https://conductscience.org/library/papers/29251719 | PubMed |
| 13 | 27558841 | Biological roles of glycans. | Glycobiology | 2017 | https://conductscience.org/library/papers/27558841 | PubMed |
| 14 | 30875782 | Mucins: the Old, the New and the Promising Factors in Hepatobiliary Carcinogenesis. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/30875782 | PubMed |
| 15 | 11278439 | Muc13, a novel human cell surface mucin expressed by epithelial and hemopoietic cells. | J Biol Chem | 2001 | https://conductscience.org/library/papers/11278439 | PubMed |
| 16 | 20639898 | The role of signaling pathways in the development and treatment of hepatocellular carcinoma. | Oncogene | 2010 | https://conductscience.org/library/papers/20639898 | PubMed |
| 17 | 29970122 | Long non-coding RNA-SNHG7 acts as a target of miR-34a to increase GALNT7 level and regulate PI3K/Akt/mTOR pathway in colorectal cancer progression. | J Hematol Oncol | 2018 | https://conductscience.org/library/papers/29970122 | PubMed |
| 18 | 21636645 | The MUC13 cell-surface mucin protects against intestinal inflammation by inhibiting epithelial cell apoptosis. | Gut | 2011 | https://conductscience.org/library/papers/21636645 | PubMed |
| 19 | 36152903 | The O-GlcNAcylation and its promotion to hepatocellular carcinoma. | Biochim Biophys Acta Rev Cancer | 2022 | https://conductscience.org/library/papers/36152903 | PubMed |
| 20 | 21450906 | Mucin 13: structure, function, and potential roles in cancer pathogenesis. | Mol Cancer Res | 2011 | https://conductscience.org/library/papers/21450906 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42340347 | Cancer-associated alterations in O-GalNAc glycosylation. | Glycobiology | 2026 | https://conductscience.org/library/papers/42340347 | PubMed |
| 42173248 | GALNT7-induced O-glycosylation of NUP50 activates fatty acid β-oxidation to promote lung adenocarcinoma metastasis. | J Biol Chem | 2026 | https://conductscience.org/library/papers/42173248 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| GALNT7 | 51809 | PubTator's text mining | https://conductscience.org/library/genes/51809 | NCBI Gene |
| MUC13 | 56667 | PubTator's text mining | https://conductscience.org/library/genes/56667 | NCBI Gene |
| PIK3CB | 5291 | PubTator's text mining | https://conductscience.org/library/genes/5291 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41439366
GET https://conductscience.org/api/papers/v1/41439366/references?page=2